Cargando…
PreS/2-21-Guided siRNA Nanoparticles Target to Inhibit Hepatitis B Virus Infection and Replication
A viable therapy is needed to overcome the deadlock of the incurable chronic hepatitis B (CHB). The prolonged existence of covalently closed circular DNA (cccDNA) and integrated HBV DNA in the nucleus of hepatocytes is the root cause of CHB. As a result, it is critical to successfully suppress HBV D...
Autores principales: | Gao, Lixia, Yang, Jie, Feng, Jutao, Liu, Ziying, Dong, Ying, Luo, Jiangyan, Yu, Liangzhentian, Wang, Jiamei, Fan, Hongying, Ma, Weifeng, Liu, Tiancai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9098953/ https://www.ncbi.nlm.nih.gov/pubmed/35572586 http://dx.doi.org/10.3389/fimmu.2022.856463 |
Ejemplares similares
-
Albumin pre-coating enhances intracellular siRNA delivery of multifunctional amphiphile/siRNA nanoparticles
por: Kummitha, China M, et al.
Publicado: (2012) -
Inhibition of SARS-CoV replication by siRNA
por: Wu, Chang-Jer, et al.
Publicado: (2005) -
In vitro inhibition of CSFV replication by multiple siRNA expression
por: Li, Jiangnan, et al.
Publicado: (2011) -
SiRNA Crosslinked Nanoparticles for the Treatment of Inflammation‐induced Liver Injury
por: Tang, Yaqin, et al.
Publicado: (2016) -
Enzyme-triggered PEGylated siRNA-nanoparticles for controlled release of siRNA
por: Yingyuad, Peerada, et al.
Publicado: (2014)